Editorial
Accepted on 18 Apr 2025
Advancements in Sex-Specific Tumor Heterogeneity
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1598740
Type at least 3 characters
26,201 articles
General Commentary
Accepted on 18 Apr 2025
Commentary: Triclabendazole Induces Pyroptosis by Activating Caspase-3 to Cleave GSDME in Breast Cancer Cells
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1583920
Case Report
Accepted on 18 Apr 2025
Crizotinib for ROS1 SCLC Case report: Durable response of immuno-chemotherapy targeting a rare ROS1 fusion-positive extensive-stage SCLC patient after primary resistance to crizotinib
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1522542
Original Research
Accepted on 17 Apr 2025
Apigenin promotes melanogenesis and melanosome transport through the c-KIT/Raf-1/MAPK/CREB pathway in HEMCs
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1572878
- 110 views
Original Research
Accepted on 17 Apr 2025
Resveratrol and N-acetylcystein reduce hepatic steatosis but enhance initiation and progression of hepatocellular carcinoma by inhibiting GST-pi-MAPK axis in mice
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1574039
Original Research
Accepted on 17 Apr 2025
Therapeutic Potential of Zinc 64 Zn Aspartate for Obesity Management: Impact on Oxidative Stress, Lipid Metabolism, Pancreas and Liver in High-Calorie Diet Model
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1543166
Review
Accepted on 17 Apr 2025
Modulating mitochondria with Natural Extract Compound: from bench to clinical therapeutic opportunities for COPD
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1531302
- 220 views
Original Research
Accepted on 17 Apr 2025
Renal tubular epithelial cell related partial epithelial-mesenchymal transition in AAâ… induced renal fibrosis via Wnt7b/β-catenin signaling
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1571960
Editorial
Accepted on 17 Apr 2025
Diabetic Kidney Disease: Routes to drug development, pharmacology and underlying molecular mechanisms, Volume II
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1609100
Original Research
Accepted on 17 Apr 2025
Exploring Indigenous Knowledge and Practices of the Gurage Community on the Biosystematics and Utilization of Enset Landraces for Bone Fracture and Regeneration: The case of Gurage zone, Central Ethiopia Region
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1563898
Original Research
Accepted on 17 Apr 2025
Nafamostat Mesylate Augments Survival in Rats Afflicted by Exertional Heat Stroke
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1559181
Original Research
Accepted on 17 Apr 2025
Berberine in the Treatment of Radiation-Induced Skin Injury: Insights from Proteomics and Network Pharmacology
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1542851
Original Research
Accepted on 17 Apr 2025
Longitudinal relationships between serum ferritin and prognosis among severe community-acquired pneumonia patients
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1556185
Original Research
Accepted on 17 Apr 2025
A Multimodal Approach to Establish ACTL6A and ERCC1 as Chemoresistance Genes in Locally Advanced Head and Neck Cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1541987
Original Research
Published on 17 Apr 2025
α-Mangostin prevents diabetic cardiomyopathy by inhibiting oxidative damage and lipotoxicity through the AKT–FOXO1–CD36 pathway
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1566311
- 264 views
Clinical Trial
Published on 17 Apr 2025
The pharmacokinetics and Concentration-QTc analysis of a new etomidate analog ET-26-HCl: a phase I trial in healthy Chinese subjects
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1534717
- 195 views